Frontlight ResearchEarly access
Hearing loss trials in United States
94 of 114 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in United StatesAural Rehab for Adult CI Outcomes
- Where
- New York
- Age
- 18 years and over
- People
- 50
- Run by
- NYU Langone Health
See details and how to joinNCT07935603 - No phaseTaking peopleEvaluating a Noise Reduction Algorithm With Cochlear Implant Users
- Where
- New York
- Age
- 12 years and over
- People
- 60
- Run by
- NYU Langone Health
See details and how to joinNCT05805384 - No phaseEnrolling by invitationAutomated Text Message Reminders to Promote Hearing Aid Adoption
- Where
- Stanford
- Age
- 18 years and over
- People
- 190
- Run by
- Stanford University
See details and how to joinNCT07170423 - No phaseEnrolling by invitationA Multilevel Intervention to Prevent Noise Exposure in Farmworkers
- Where
- San Diego
- Age
- 18 years and over
- People
- 200
- Run by
- San Diego State University
See details and how to joinNCT07554378 - No phaseTaking peopleHEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
- Where
- Baltimore
- Age
- 60 years to 100 years
- People
- 300
- Run by
- Johns Hopkins University
See details and how to joinNCT06930560 - Phase 1/2Taking peopleAnti-VEGF Gene Therapy Trial for Vestibular Schwannoma
- Where
- Baltimore, Dallas, Nashville, Rochester
- Age
- 18 years and over
- People
- 27
- Run by
- Eli Lilly and Company
See details and how to joinNCT06517888 - No phaseTaking peopleBarriers and Facilitators to OTC Hearing Aids Success
- Where
- Iowa City, Nashville
- Age
- 18 years to 89 years
- People
- 360
- Run by
- Yu-Hsiang Wu
See details and how to joinNCT06499805 - No phaseTaking peopleInvestigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants
- Where
- New York
- Age
- 2 years to 90 years
- People
- 200
- Run by
- NYU Langone Health
See details and how to joinNCT05810220 - No phaseTaking peopleFall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device
- Where
- Palo Alto
- Age
- 55 years and over
- People
- 350
- Run by
- Stanford University
See details and how to joinNCT05365646 - No phaseTaking peopleAssessing Pharmacy Technician Educational Training for the Provision of Over-the-Counter Hearing Aids in Rural Alabama and Mississippi Pharmacies
- Where
- Tuscaloosa
- Age
- 18 years and over
- People
- 144
- Run by
- University of Alabama, Tuscaloosa
See details and how to joinNCT06864273 - Phase 3Taking peopleKHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
- Where
- Boston, Cleveland, Houston
- Age
- 18 years to 64 years
- People
- 220 worldwide
- Run by
- Khondrion BV
See details and how to joinNCT06451757 · EU 2025-522361-30-00 - No phaseTaking peopleImproving Cochlear Implant Outcomes Through Modeling and Programming Strategies Based on Human Inner Ear Pathology
- Where
- Boston
- Age
- 18 years to 80 years
- People
- 45
- Run by
- Massachusetts Eye and Ear Infirmary
See details and how to joinNCT07683689 - No phaseTaking peopleHearing Impairment, Strategies and Outcomes in VA Emergency Departments
- Where
- Aurora, Dallas, Durham, New York, Syracuse, The Bronx
- Age
- 60 years and over
- People
- 1,050
- Run by
- VA Office of Research and Development
See details and how to joinNCT05028972 - Phase 1/2Not yet taking people in United StatesA Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
- Where
- Washington D.C.
- Age
- 18 years to 65 years
- People
- 24
- Run by
- George Washington University
See details and how to joinNCT06792500 - Phase 2Taking peoplePrevention of Ototoxicity in NTM Patients Treated With IV Amikacin
- Where
- Baltimore, Charleston, Denver, Manhasset, Portland, Rochester, San Francisco, Tyler
- Age
- 18 years to 80 years
- People
- 105
- Run by
- Kevin Winthrop
See details and how to joinNCT05730283 - Phase 3Taking peopleGene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
- Where
- Boston, Cincinnati, Iowa City, Nashville, Philadelphia, San Francisco
- People
- 48 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05821959 · EU 2026-525943-33-00 - No phaseTaking peopleImproving Spatial Perception and Speech Understanding in Multitalker Mixtures
- Where
- Boston
- Age
- 18 years to 80 years
- People
- 220
- Run by
- Boston University Charles River Campus
See details and how to joinNCT05260307 - No phaseTaking peopleEvaluation of Flexible Conductive Hearing Aids
- Where
- Winston-Salem
- Age
- 6 months to 80 years
- People
- 200
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT07222202 - No phaseNot yet taking people in United StatesThe Hear Clear Study
- Where
- Columbus, Durham
- Age
- 18 years and over
- People
- 125
- Run by
- Duke University
See details and how to joinNCT07824115 - No phaseTaking peopleOTC Hearing Aid and MCI
- Where
- Evanston, La Crosse, Madison
- Age
- 60 years to 90 years
- People
- 50
- Run by
- Northwestern University
See details and how to joinNCT06112860 - Phase 2Taking peopleAtorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
- Where
- Atlanta, Baltimore, Bethesda, Fairfax, Rochester
- Age
- 18 years to 100 years
- People
- 224
- Run by
- National Institute on Deafness and Other Communication Disorders (NIDCD)
See details and how to joinNCT04915183 - No phaseTaking peopleAuditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves
- Where
- New York
- Age
- 18 months to 21 years
- People
- 20
- Run by
- NYU Langone Health
See details and how to joinNCT02310399 - Phase 1/2Taking peopleOpen-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing Loss
- Where
- Allentown, Bethesda, Boston, Oklahoma City
- Age
- 9 months to 7 years
- People
- 10
- Run by
- Skylark Bio Inc.
See details and how to joinNCT07627971 - Phase 3Taking peopleA Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Where
- Akron, Albany, Ann Arbor, Atlanta, Aurora, Austin, Baltimore, Birmingham, Boston, Buffalo, Chapel Hill, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Des Moines, Detroit, El Paso, Fargo, Fort Myers, Grand Rapids, Greenville, Hartford, Hollywood, Honolulu, Indianapolis, Iowa City, Jackson, Jacksonville, Kansas City, Knoxville, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Madera, Madison, Marshfield, Miami, Milwaukee, Minneapolis, Mobile, Nashville, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Oklahoma City, Omaha, Orange, Orlando, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Richmond, Rochester, Royal Oak, Sacramento, San Antonio, San Diego, San Francisco, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Valhalla, Washington D.C., Wilmington, Winston-Salem
- Age
- 4 years to 21 years
- People
- 225 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05382338 - No phaseTaking peopleListening Effort in Cochlear Implant Users
- Where
- Minneapolis
- Age
- 18 years to 75 years
- People
- 400
- Run by
- University of Minnesota
See details and how to joinNCT06516575